baber/WOPTO huggingface dataset:
Patent CA-2855838-A1 (CA)
Inventor: HWANG JENNIFER HUI-NI
IPC: G06Q50/30
Filed: 2012-11-16
Abstract: Systems, methods, and software are described herein for enhancing features within program applications. In an implementation, a user associated with a productivity application is identified and a service application associated with the user is identified. A service feature that corresponds to the service is enabled within the productivity application. The service feature allows the user to perform a function on content generated with the productivity application that is related to the service.
Patent CA-2856622-A1 (CA)
Title: A gripper having a two degree of freedom underactuated mechanical finger for encompassing and pinch grasping
Inventor: ALLEN DEMERS LOUIS-ALEXIS
IPC: B25J15/08
Filed: 2012-11-23
Abstract: A mechanical gripper being adapted to automatically perform a stable pinch grasp and an encompassing grasp and a method of determining a system geometry thereof. The gripper comprising at least one mechanical finger comprising. The at least one mechanical finger comprising a first phalanx and a second phalanx that are pivotally connected. When a load is applied on a stable pinch grasp region, an actuation mechanism is adapted to allow the second phalanx to translate and allow its contact surface to maintain a constant orientation in order to automatically perform a pinch grasp, when a load is applied on the first phalanx or below the stable pinch grasp region, the actuation mechanism is adapted to allow the second phalanx to pivot and automatically perform an encompassing grasp.
Patent CA-2862718-A1 (CA)
Title: Triazolopyridine derivatives as a tyrosine kinase inhibitor
Inventor: SIM JAE YI
IPC: C07D249/16
Filed: 2013-01-23
Abstract: Provided is a novel triazolopyridine derivative having irreversible tyrosine kinase inhibiting activities, and a pharmaceutical composition comprising the same which can be useful for prevention or treatment of inflammatory diseases, autoimmune diseases, proliferative diseases or hyperproliferative diseases, immunologically mediated diseases, cancers or tumors.
Patent CA-2863166-A1 (CA)
Inventor: SKOVBY MICHAEL
IPC: C04B40/00
Filed: 2013-02-27
Abstract: Process for the preparation of cement / mortar / concrete compositions or systems, (for simplicity hereafter "cement" compositions or systems), featuring an improved compressive strength Rc namely at 28 days and 90 days, containing at least a "carbonate-based filler", comprising at least one step where the said at least one "carbonate-based filler" is mixed or blended with at least one aluminosiliceous material, and the obtained "fillers blend" is treated with an efficient treating amount of at least one treating agent consisting of or comprising superplastifier(s); PRODUCT comprising at least a " carbonate- based "filler" " as defined and at least an aluminosiliceous material, what provides a "fillers blend"; cement compositions, use of the said "fillers(s) blends" and cement composition; cement elements or cement products" obtained from the said "cements compositions", such as construction or building blocks.
Patent CA-2864597-A1 (CA)
Inventor: MULLANEY NICHOLAS BRUCE
IPC: B65D88/12
Filed: 2013-02-12
Abstract: A height adjustable shipping container usable as a building structure (2400). The container having vertical corner columns (2405) and at least three side walls which may be transported at a reduced height as a shipping container and expanded at the receiving end. At least some of the vertical corner columns (2405) expand in length during expansion of the reduced height shipping container. The shipping container is able to transport therein structural components, such as wall panel (2403, 2404, floor 2401), roof (2402A, 2402B) and even fittings to build a building structure that is the equivalent in floor area to that of at least two shipping containers.
Patent CA-2865068-A1 (CA)
Inventor: SCOTT KENNY
IPC: E02D29/02
Filed: 2012-12-28
Abstract: The present invention relates to a gabion deployment platform for storing a folded multi-compartment gabion and from which the gabion can be deployed, the deployment platform comprising: a base element for supporting the folded multi-compartmental gabion, the base element comprising a first member configured to extend along at least a part of a first side of said folded multi-compartment gabion, and a second member, extending transversely from said first member, said second member configured to extend along at least a part of a second side of said folded multi-compartmental gabion; and at least one retaining element, coupled at a first end thereof to said base element, said at least one retaining element being releasably attached, connected or retentively engaged, at least at one point of said at least one retaining element, by way of at least one releasable attaching, connecting or retentive engaging means, to a portion of a compartment of said folded multi-compartment gabion, said at least one retaining element configured to extend from said base element, over at least a portion of said folded multi-compartment gabion, said at least one retaining element serving to attach, connect or retentively engage a part of the gabion to the base element when the gabion is folded but to release the gabion from the base element when the gabion is deployed.
Patent CA-2866385-A1 (CA)
Title: Top piece for a corresponding pin-shaped dental implant
Inventor: KERN MARIO
IPC: A61C8/00
Filed: 2013-03-12
Abstract: Attachment (1) for a corresponding pin-shaped tooth implant (2), with: a platform (3), which has a first platform surface (4) and a second platform surface (5), a retention pin (8) arranged on the first platform surface (4) and used to secure a mesostructure (9), a connection pin (6) for connecting the platform (3) to a pin-shaped tooth implant (2) having a blind bore (7) corresponding to the connection pin (6), wherein, in a first variant, the edge of the platform (3) is designed curving in a direction away from the connection pin (6) and, in a second variant, the diameter (D) of the platform (3), at least over a part (F1, F2) of the total angle range (F1, F2, F3, F4), is so great that, in the state when the attachment (1) is connected to the corresponding pin-shaped tooth implant (2), the platform (3), in a plan view of the second platform surface (5), protrudes beyond the corresponding pin-shaped tooth implant (2).
Patent CA-2872437-A1 (CA)
Title: Geometrie de sonde d'oxymetrie de tissu pour l'etalonnage et la correction automatique robustes
Inventor: BECHTEL KATE LEEANN
IPC: A61B5/1455
Filed: 2013-05-03
Abstract: Une tête de capteur pour le dispositif capteur d'oxymètre compact selon l'invention comprend des sources de lumière et des détecteurs de lumière. Selon un mode de réalisation, le dispositif capteur d'oxymètre compact est entièrement intégré, sans besoin de le connecter, avec ou sans fil, à une unité de système séparée. Les sources et détecteurs sont agencés de manière circulaire avec des distances de paires source-détecteur variées qui permettent un étalonnage et une correction automatique robustes dans une sonde compacte. D'autres agencements source-détecteur sont aussi possibles.
Patent CA-2873431-A1 (CA)
Title: Vecteurs raav a efficacite elevee de transduction, compositions et methodes d'utilisation
Inventor: SRIVASTAVA ARUN
IPC: C12N15/35
Filed: 2013-05-15
Abstract: La présente invention concerne des protéines de capside d'AAV (virus adéno-associés) comprenant une modification de l'un des résidus de lysine, de sérine, de thréonine et/ou de tyrosine exposés à la surface dans la région VP3, ou d'une combinaison de ceux-ci. La présente invention concerne également des virions de rAAV (virus adéno-associés de recombinaison) comprenant les protéines de capside d'AAV de la présente invention, ainsi que des molécules d'acide nucléique et des vecteurs de rAAV codant pour les protéines de capside d'AAV de la présente invention. Les vecteurs et les virions de rAAV de la présente invention présentent, de manière avantageuse, une efficacité de transduction améliorée d'une variété de cellules, de tissus et d'organes d'intérêt, par rapport à des vecteurs et des virions de rAAV du type sauvage.
Patent CA-2873634-A1 (CA)
Title: Composition pharmaceutique comprenant de la (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine et des antidepresseurs
Inventor: FROSCH STEFANIE
IPC: A61P29/00
Filed: 2013-05-16
Abstract: L'invention porte sur une composition pharmaceutique comprenant un premier principe pharmacologiquement actif choisi parmi la (1R,4R)-6'-fluoro-N,N-diméthyl-4-phényl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine et les sels physiologiquement acceptables de celle-ci et un second principe pharmacologiquement actif qui est un antidépresseur.
Patent CA-2873897-A1 (CA)
Inventor: RHDEN ROLF
IPC: F03D1/06
Filed: 2013-05-28
Abstract: An apparatus for assembling blade sections for forming a blade is provided. The apparatus comprises at least two members (1, 2) movable with respect to each other, said members having respective opposing surfaces (2A, 2B) forming a pressing space for pressing outer surfaces of preassembled blade sections in a transition between the sections.
Patent CA-2875683-A1 (CA)
Inventor: JACKSON RONALD JAMES
IPC: A61P31/00
Filed: 2013-06-05
Abstract: The invention relates to methods for inducing an antigen-specific immune response, methods for increasing the avidity of immune cells for an antigen, methods for increasing the number of immune cells specific for an antigen, methods of preventing or treating infection and methods of vaccinating, the methods comprising administering an interleukin-4 receptor (LL-4R) antagonist in combination with an antigen, in particular HIV-1 antigens selected from a gag, pol, or env.
Patent CA-2876499-A1 (CA)
Inventor: WANG XIAOFANG
IPC: C12N5/00
Filed: 2013-06-27
Abstract: The present invention relates to methods of generating and expanding hitman embryonic stem eel! derived mesenchymal-iike stem/siromal cells. These hES-MSCs are characterized at least in part by the low level of expression of IL-6. These cells are useful for the prevention and treatment of T cell related autoimmune disease, especially multiple sclerosis, as well as for delivering agents across the blood-brain barrier and the blood-spinal cord barrier. Also provided is a method of selecting clinical grade hES-MSC and a method of modifying MSC to produced a MSC with specific biomarker profile. The modified MSC are useful for treatment of various diseases.
Patent CA-2880285-A1 (CA)
Inventor: MCCLAIN SEAN
IPC: C12N15/70
Filed: 2013-08-05
Abstract: The present invention is an inducible coexpression system, capable of controlled induction of expression of each gene product.
Patent CA-2881271-A1 (CA)
Inventor: NIELSEN FRANK
IPC: F41H5/04
Filed: 2013-08-05
Abstract: Future fighting vehicles will require lighter, stronger and more space efficient armor for better protection, better survivability and better mobility. The invented lightweight armor component consists of armor-grade material (2), such as ceramic, encapsulated in fiber reinforced cementitious composite (FRCC) (1). The encapsulation FRCC pre-stress the armor-grade material. The resulting armor component of the present disclosure provides excellent ballistic protection against most types and sizes of Kinetic Energy (KE) threats and Chemical Energy (CE) threats. The armor component has low areal density, reduced damage area, improved multi-hit capability, flexible design and also provides high structural strength. It furthermore has the advantage, that it can be formed in virtually any shape. The present disclosure results in superior ballistic characteristics of an armor component. An object of the present disclosure is to increase penetration resistance of especially ceramic based armor, while lowering system weight.
Patent CA-2881467-A1 (CA)
Title: Crystalline forms of 1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'h-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone
Inventor: BILLEN DENIS
IPC: C07D491/107
Filed: 2013-08-28
Abstract: The present invention relates to novel crystalline modifications of 1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone. The present invention also describes compositions and methods of treating a parasitic infection or infestation in an animal in need thereof. The present invention also relates to processes for making the crystalline forms.
Patent CA-2882971-A1 (CA)
IPC: F01B17/02
Filed: 2015-02-24
Abstract: The invention provides a method of converting a combination of applied force and gravity force collected from vehicles driving over a series of plates recessed in a section of road into useful mechanical motion. The plates are housed in a steel box and attached to a crankshaft by connecting rods. When the plates are depressed sequentially they cause the crankshaft to rotate. A gear is attached to the end of the crankshaft.
Patent CA-2885696-A1 (CA)
Inventor: WANG YIRAN
IPC: C21D8/10
Filed: 2013-09-26
Abstract: The present invention discloses a high-frequency straight welded pipe. The high-frequency straight welded pipe comprises the following chemical element percentages by mass: 0.042-0.056% of C, 0.18-0.22% of Si, 0.75-0.95% of Mn, 0.0064-0.015% of P, 0.0006-0.002% of S, 0.012-0.018% of Ti, 0.001-0.002% of V, 0.026-0.038% of Al, 0.080-0.13% of Ni, 0.020-0.029% of Nb, 0.125-0.135% of Cu, 0.018-0.03% of Cr, 0.004-0.008% of Mo, 0-0.0005% of B, 0.001-0.003% of Ca, and the balance of Fe and other inevitable impurities. Meanwhile, further disclosed is a manufacturing method for the high-frequency straight welded pipe.
Patent CA-2885745-A1 (CA)
Inventor: MEVIUS JASON S
IPC: G05D16/10
Filed: 2013-09-27
Abstract: A fluid regulating device includes a regulator valve having a valve body defining an inlet and an outlet and a valve port disposed between the inlet and the outlet. A housing assembly is disposed adjacent the valve port, and the housing assembly includes a first aperture adapted to receive a valve disc. A balancing diaphragm is secured to a portion of the valve disc and a portion of the housing assembly, and a portion of a balancing cavity is defined by a top surface of the balancing diaphragm and an interior surface of the housing assembly. A sensing passage extends from the inlet of the regulator valve to the balancing cavity such that the inlet of the regulator valve is in fluid communication with the balancing cavity.
Patent CA-2885990-A1 (CA)
Title: Method for effecting a photocatalytic or photoelectrocatalytic reaction
Inventor: IRVINE JOHN THOMAS SIRR
IPC: B01J23/20
Filed: 2012-10-25
Abstract: The invention provides a method for effecting a photocatalytic or photoelectrocatalytic reaction of a reactant comprising contacting a metallic material having an electrical conductivity of 105 to 106 S/m with the reactant and exposing the metallic material and the reactant to visible light so as to catalyse the reaction of the reactant.
Patent CA-2886283-A1 (CA)
Inventor: AAMER KHALED ABDEL-HAKIM HELMY
IPC: B01D71/06
Filed: 2015-03-26
Abstract: Disclosed are membranes formed from self-assembling block copolymers, for example, a diblock copolymer of the formula (I): (see formula I) wherein R1-R4, n, and m are as described herein, which find use in preparing nanoporous membranes. Embodiments of the membranes contain the block copolymer that self-assembles into a cylindrical morphology. Also disclosed is a method of preparing such membrane which involves spray coating a polymer solution containing the diblock copolymer to obtain a thin film, followed by annealing the thin film in a solvent vapor and/or soaking in a solvent or mixture of solvents to form a nanoporous membrane.
Patent CA-2886544-A1 (CA)
Inventor: AMREIN MATHIAS W
IPC: A61P39/04
Filed: 2012-09-27
Abstract: The use of cholesterol-sequestering agents, such as methyl-beta-cyclodextrin, for the treatment of pulmonary surfactant dysfunction is disclosed. It was discovered that oxidative damage to pulmonary surfactant arises due to the interaction between reactive oxygen species and cholesterol. Thus, by removing cholesterol from pulmonary7 surfactant through the addition of a cholesterol-sequestering agent, oxidative damage to the surfactant is mitigated. It was also shown that methyl-beta-cyclodextrin can restore normal function to dysfunctional surfactant removed from the lungs of children with cystic fibrosis and non cystic fibrosis bronchiolitis.
Patent CA-2886786-A1 (CA)
Inventor: ALSHAIKH ABDULLATIF SALEH ABDULLAH
IPC: E04G15/06
Filed: 2013-09-26
Abstract: A shrinkable core (100) for inserting in a mold (200) for forming a precast load bearing wall panel having a cavity, the shrinkable core (100) comprises a first wall (110) and a second wall (120), a first side element (112) and a second side element (122), and a spacing element (130). The first wall (110) and second wall (120) are spaced from to each other by a first distance (dl) to define an internal region (115) in-between. The first side element (1 12) and the second side element (122) are arranged to close opposite edge portions of the spaced first wall (110) and second wall (120) such that fluid concrete cannot pass the opposite edge portions to get into the internal region (115), the first side element (112) and second side element (122) being spaced by a second distance (d2). The spacing element (130) is configured to vary at least one of the first distance (dl) and the second distance (d2) such that a circumference along the first and second walls (110, 120) and the first and second side elements (112, 122) shrinks monotonically with lowering said at least one distance.
Patent CA-2887136-A1 (CA)
Title: Indol-amide compounds as beta-amyloid inhbitors
Inventor: BAUMANN KARLHEINZ
IPC: A61K31/497
Filed: 2013-10-15
Abstract: The present invention provides compounds of formula (I), wherein Z, R1, R2, and R3 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. Further the present invention is concerned with the manufacture of the compounds of formula (I), pharmaceutical compositions comprising them and their use as medicaments for the treatment of Alzheimer's disease.
Patent CA-2887559-A1 (CA)
Title: Mixer and reactor and process incorporating the same
Inventor: TIRTOWIDJOJO MAX MARKUS
IPC: B01F5/06
Filed: 2013-10-14
Abstract: The present invention relates to a mixer, an apparatus comprising the mixer and a reactor, and processes incorporating the same. The mixer comprises an inlet (104) to a chamber (102), wherein the chamber inlet angle is less than 90°. The mixer further comprises an expander zone (106) that expands outwardly at an expander angle of less than 90°. The mixer may be coupled to a reactor at its outlet, which may closely approximate the size of the reactor inlet due to the expander (106).
Patent CA-2887765-A1 (CA)
Title: Waste management cart with advertising panels
Inventor: DANIELL GARY A
IPC: G09F21/04
Filed: 2015-04-08
Abstract: Provided is a cart having a frame, a set of wheels attached to the frame for transporting the cart, an upper shelf and a lower shelf for supporting waste management items, and at least one advertising panel attached to the frame for displaying advertising. Provided is a method for assembling a cart including attaching a frame to a lower shelf, attaching the frame to the upper shelf, and attaching at least one advertising panel to the frame.
Patent CA-2887937-A1 (CA)
Title: Procede de desactivation d'un module de paiement, produit programme informatique correspondant, support de donnees et module de paiement
Inventor: NACCACHE DAVID
IPC: G06Q20/00
Filed: 2015-04-10
Abstract: Linvention concerne une méthode pour désactiver un module de paiement pouvant être attaché à un terminal de communications : .cndot. une phase pour la désactivation comprenant au moins une étape pour effacer la mémoire principale dudit module de paiement, à lexception dune zone de mémoire non volatile dans laquelle une clé de chiffrement est stockée, ladite clé de chiffrement k étant disponible seulement lorsque ladite mémoire principale est vide; .cndot. une phase pour la vérification comprenant : .circle. une étape pour vérifier que ladite mémoire principale est vide, produisant une réponse dun résultat positif ou négatif de la vérification; .circle. si ledit résultat de la vérification est positif : .cndot. une étape pour le calcul dune réponse à un défi dabord reçu par ledit module de paiement dune entité séparée dudit module de paiement, ledit calcul étant mis en application au moyen de ladite clé de chiffrement k; .cndot. une étape pour la transmission de ladite réponse à ladite entité.
Patent CA-2891428-A1 (CA)
Inventor: HORN GAVIN B
IPC: H04W56/00
Filed: 2009-01-27
Abstract: Systems and methodologies are described that facilitate synchronizing timing among wireless nodes in a wireless communication network. A tracking wireless node can synchronize to a global positioning system (GPS) signal if available. Alternatively, the tracking wireless node can receive quality metrics related to one or more target nodes. The quality metrics can relate to parameters that can be utilized to evaluate the target node for timing synchronization. Based on the quality metrics, the tracking wireless node can select a target wireless node for timing synchronization. The tracking wireless node can subsequently synchronize timing with the target wireless node. In addition, the tracking wireless node can continually evaluate surrounding wireless nodes to detect whether other wireless nodes have higher quality metrics than the current target wireless nodes and can accordingly resynchronize with nodes having higher metrics.
Patent CA-2891489-A1 (CA)
Inventor: BARNES ANDREW PHILIP
IPC: F16N19/00
Filed: 2013-11-19
Abstract: A replaceable fluid container for an engine comprising: a reservoir for holding a fluid; a fluid coupling adapted to provide fluidic communication between the reservoir and a fluid circulation system of an engine; and a data provider arranged such that positioning the container to permit fluidic communication between the reservoir and the fluid circulation system of the engine arranges the data provider for data communication with an engine control device of the engine. There is also provided a method of facilitating control of an engine and an engine control system, apparatus and a vehicle.
Patent CA-2893077-A1 (CA)
Inventor: WACHENDORFF-NEUMANN ULRIKE
IPC: A01N63/30
Filed: 2013-12-03
Abstract: The present invention relates to a composition comprising at least one biological control agent selected from the group consisting of Paecilomyces lilacinus strain 251 (AGAL No. 89/030550) and Coniothyrium minitans CON/M/91 -08 (DSM 9660) and/or a mutant of these strains having all the identifying characteristics of the respective strain, and/or at least one metabolite produced by the respective strain that exhibits activity against nematodes, insects and/or phytopathogens, and at least one fungicide (I) selected from the group consisting of inhibitors of the ergosterol biosynthesis in a synergistically effective amount. Furthermore, the present invention relates to a kit of parts comprising said composition and the use of said composition.
Patent CA-2893266-A1 (CA)
Title: Oxygen system having sensors with a passive rfd interface
Inventor: RICHARDSON CHAD
IPC: G01L19/14
Filed: 2013-10-31
Abstract: A passively powered gas sensor for remotely reading and transmitting a gas pressure of a system, comprising a hollow cylindrical body, a stem axially aligned and extending outwardly from a first surface of the hollow cylindrical body, a pressure sensing element in the stem, and an antenna coupled to the pressure sensing element, where the antenna is located within the hollow cylindrical body and the stem. The pressure sensing device is polled remotely by a polling device, and powered by the polling device.